Table 4. Odds ratios for having adverse lipid concentrations per SD increment of BMI in individuals stratified by sex, age (<60 yr and ≥60 yr) and prevalence of MS.
| Sex* | Age# | MS& | ||||
|---|---|---|---|---|---|---|
| Male | Female | <60 yr | ≥60 yr | Without | With | |
| SD of BMI (kg/m2) | 2.52 | 2.50 | 2.45 | 2.55 | 2.47 | 2.05 |
| High TC | ||||||
| OR (95%CI) | 0.93 (0.56–1.58) | 0.95 (0.72–1.26) | 0.95 (0.66–1.36) | 0.87 (0.62–1.24) | 0.97 (0.72–1.31) | 0.93 (0.65–1.33) |
| P-value | 0.78 | 0.74 | 0.76 | 0.44 | 0.86 | 0.66 |
| High LDL-C | ||||||
| OR (95%CI) | 1.31 (0.98–1.77) | 1.22 (1.00–1.50) | 1.16 (0.91–1.50) | 1.22 (0.97–1.53) | 1.26 (1.03–1.55) | 1.13 (0.90–1.44) |
| P-value | 0.07 | 0.06 | 0.24 | 0.09 | 0.02 | 0.29 |
| Low HDL-C | ||||||
| OR (95%CI) | 1.60 (1.32–1.96) | 1.52 (1.26–1.85) | 1.45 (1.18–1.80) | 1.66 (1.39–1.99) | 1.57 (1.29–1.91) | 1.23 (1.03–1.46) |
| P-value | < .0001 | < .0001 | 0.0006 | < .0001 | < .0001 | 0.02 |
| Hypercholesterolemia | ||||||
| OR (95%CI) | 1.53 (1.25–1.88) | 1.46 (1.25–1.72) | 1.35 (1.12–1.63) | 1.57 (1.33–1.87) | 1.40 (1.20–1.64) | 1.25 (1.04–1.50) |
| P-value | < .0001 | < .0001 | 0.0016 | < .0001 | < .0001 | 0.02 |
| Hypertriglyceridemia | ||||||
| OR (95%CI) | 1.06 (0.81–1.39) | 1.31 (1.06–1.63) | 1.20 (0.95–1.52) | 1.30 (1.03–1.65) | 0.94 (0.71–1.24) | 1.14 (0.94–1.37) |
| P-value | 0.68 | 0.01 | 0.13 | 0.03 | 0.65 | 0.18 |
| Dyslipidemia | ||||||
| OR (95%CI) | 1.47 (1.20–1.80) | 1.43 (1.23–1.67) | 1.36 (1.14–1.63) | 1.51 (1.28–1.79) | 1.33 (1.15–1.55) | 1.27 (1.05–1.54) |
| P-value | 0.0002 | < .0001 | 0.0007 | < .0001 | 0.0002 | 0.02 |
*Adjusted for age, smoking, WC, HC, SBP, DBP, FBG, PBG, HbA1c, history of cardiovascular disease and lipid-lowering therapy
#Adjusted for sex, age, smoking, WC, HC, SBP, DBP, FBG, PBG, HbA1c, history of cardiovascular disease and lipid-lowering therapy
&Adjusted for sex, age, smoking, WC, HC, SBP, DBP, FBG, PBG, HbA1c, history of cardiovascular disease and lipid-lowering therapy.